Do pharmacogenomic tests provide value to policy makers?

Pharmacoeconomics. 2006;24(12):1173-7. doi: 10.2165/00019053-200624120-00002.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Cost-Benefit Analysis
  • Costs and Cost Analysis
  • Humans
  • Pharmacogenetics / economics*
  • Pharmacogenetics / legislation & jurisprudence*
  • Quality-Adjusted Life Years